Apex Capital’s Allergan plc AGN Stock Holding History

Apex Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$31.5M	Sell	100,750 -124,250	-55%	-$37M	3.36%	9
2015 Q3	$61.2M	Buy	225,000 +50,000	+29%	+$15.4M	5.81%	1
2015 Q2	$53.1M	Hold	175,000	–	–	4.6%	4
2015 Q1	$52.1M	Buy	175,000 +19,200	+12%	+$5.47M	3.74%	6
2014 Q4	$40.1M	Sell	155,800 -44,200	-22%	-$11M	2.81%	9
2014 Q3	$48.3M	Sell	200,000 -75,000	-27%	-$16.8M	3.42%	6
2014 Q2	$61.3M	Sell	275,000 -75,000	-21%	-$15.5M	3.83%	4
2014 Q1	$72M	Buy	350,000 +40,000	+13%	+$7.92M	5.06%	2
2013 Q4	$52.1M	Buy	310,000 +135,000	+77%	+$21.1M	3.44%	6
2013 Q3	$25.2M	Buy	175,000 +77,000	+79%	+$10.3M	1.81%	17
2013 Q2	$12.4M	Buy	+98,000	New	+$11.1M	0.85%	46

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Apex Capital's AGN Position: Q4 2015 in Review

Apex Capital reduced its Allergan plc (AGN) stake by 55% in Q4 2015, selling an estimated $37M and leaving 100,750 shares worth $31.5M. The position accounts for 3.36% of the portfolio, ranked #9.

Apex Capital first reported a position in AGN in Q2 2013 and has held it in 11 quarters since. The position peaked at $72M in Q1 2014. 1,111 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

Apex Capital held 100,750 shares of Allergan plc worth $31.5M as of Q4 2015.
Apex Capital sold 124,250 Allergan plc shares in Q4 2015, an estimated $37M.
Allergan plc made up 3.36% of Apex Capital's portfolio in Q4 2015, its #9 holding.
Apex Capital first reported a position in Allergan plc in Q2 2013 and has held it in 11 quarters since.
Apex Capital's Allergan plc position peaked at $72M in Q1 2014.
1,111 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Apex Capital's 13F filing for Q4 2015, filed 16 Feb 2016.